Search Results | Cancer Research | American Association for Cancer Research

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Abstract PS8-13: Silicone implant based sustained localized drug delivery of fulvestrant to prevent breast cancer

Pamela N Munster, Pujan K Desai, Nela Pawlowska, Elysia Roche, Romain Pacaud, Maxim A Daud, Emily Hsu, David Gingrich, Amelia Deitchman, Fran Aweeka, Scott Thomas

Cancer Res (2021) 81 (4_Supplement): PS8-13.

DOI: https://doi.org/10.1158/1538-7445.SABCS20-PS8-13

Published: 15 February 2021

View article

Journal Articles

Abstract CT051: Carboplatin and talazoparib combination therapy results in differential efficacy and hematologic toxicity in BRCA-mutated patients

Mallika S. Dhawan, Rahul Aggarwal, Imke Bartelink, Jim Leng, Scott Thomas, Nela Pawlowska, Laurie Stevenson, Amy Jo Chien, Robin Kate Kelley, Pamela N. Munster

Cancer Res (2016) 76 (14_Supplement): CT051.

DOI: https://doi.org/10.1158/1538-7445.AM2016-CT051

Published: 15 July 2016

View article

Journal Articles

Abstract CT016: Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: a phase I study in advanced solid tumor malignancies

Rahul Aggarwal, Scott Thomas, Jennifer Grabowsky, Armand Harb, Jim Leng, Anne Reinert, Ilaria Mastroserio, Thach-Giao Truong, Pamela N. Munster

Cancer Res (2016) 76 (14_Supplement): CT016.

DOI: https://doi.org/10.1158/1538-7445.AM2016-CT016

Published: 15 July 2016

View article

Journal Articles

Abstract 2614: Inhibition of class I histone deacetylases attenuates anthracycline induced activation of the ATM pathway

Kenneth (Ted) Thurn, Scott Thomas, Paromita Raha, Ian Qureshi, Pamela N. Munster

Cancer Res (2011) 71 (8_Supplement): 2614.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2614

Published: 15 April 2011

View article

Journal Articles

Abstract 2631: The HDAC inhibitor PCI-24781 potentiates the anti-tumor activity of tamoxifen in ER-positive breast cancer cells

Scott Thomas, K.Ted Thurn, Paromita Raha, Pamela N. Munster

Cancer Res (2011) 71 (8_Supplement): 2631.

DOI: https://doi.org/10.1158/1538-7445.AM2011-2631

Published: 15 April 2011

View article

Journal Articles

CRM1 knockdown by ratjadone C, leptomycin B, and siRNA to CRM1, enhance sensitivity of human multiple myeloma cells to topoisomerase II inhibitors.

Joel G. Turner, Douglas C. Marchion, Edward R. Seijo, Michael F. Emmons, Lori A. Hazlehurst, Pamela N. Munster, Peter Washausen, Daniel M. Sullivan

Cancer Res (2006) 66 (8_Supplement): 1277.

Published: 15 April 2006

View article

Journal Articles

Histone deacetylase inhibitors: evaluation of biological correlates as predictive markers in in vivo and in vitro models.

Adil I. Daud, Douglas C. Marchion, Elona Bicaku, Morgan Schmitt, Pamela N. Munster

Cancer Res (2006) 66 (8_Supplement): 1185–1186.

Published: 15 April 2006

View article

Journal Articles

Valproic acid sensitizes human melanoma cells to karenitecin in vitro and in vivo

Jana L. Gump, Douglas C. Marchion, Elona Bicaku, Joel G. Turner, Frederick H. Hausheer, Adil I. Daud, Pamela N. Munster, Daniel M. Sullivan

Cancer Res (2006) 66 (8_Supplement): 320.

Published: 15 April 2006

View article

Journal Articles

Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins

Douglas C. Marchion, Elona Bicaku, Adil I. Daud, Daniel M. Sullivan, Pamela N. Munster

Cancer Res (2005) 65 (9): 3815–3822.

DOI: https://doi.org/10.1158/0008-5472.CAN-04-2478

Published: 02 May 2005

View article

Journal Articles

Histone deacetylase and topoisomerase inhibitors: Exploration of a synergistic interaction in breast and melanoma xenograft models

Adil I. Daud, Douglas C. Marchion, Elona Bicaku, Joel Turner, Pamela N. Munster

Cancer Res (2005) 65 (9_Supplement): 424.

Published: 01 May 2005

View article

Journal Articles

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Differentiation of Human Breast Cancer Cells

Pamela N. Munster, Tiffany Troso-Sandoval, Neal Rosen, Richard Rifkind, Paul A. Marks, Victoria M. Richon

Cancer Res (2001) 61 (23): 8492–8497.

Published: 01 December 2001

View article

NARROW

Abstract PS8-13: Silicone implant based sustained localized drug delivery of fulvestrant to prevent breast cancer

Abstract CT051: Carboplatin and talazoparib combination therapy results in differential efficacy and hematologic toxicity in BRCA-mutated patients

Abstract CT016: Abexinostat (ABX) as a means to reverse pazopanib (PAZ) resistance: a phase I study in advanced solid tumor malignancies

Abstract 2614: Inhibition of class I histone deacetylases attenuates anthracycline induced activation of the ATM pathway

Abstract 2631: The HDAC inhibitor PCI-24781 potentiates the anti-tumor activity of tamoxifen in ER-positive breast cancer cells

CRM1 knockdown by ratjadone C, leptomycin B, and siRNA to CRM1, enhance sensitivity of human multiple myeloma cells to topoisomerase II inhibitors.

Histone deacetylase inhibitors: evaluation of biological correlates as predictive markers in in vivo and in vitro models.

Valproic acid sensitizes human melanoma cells to karenitecin in vitro and in vivo

Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins

Histone deacetylase and topoisomerase inhibitors: Exploration of a synergistic interaction in breast and melanoma xenograft models

The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Induces Differentiation of Human Breast Cancer Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only